A Clinical Curriculum for Responsible MDMA-Assisted Therapy
Get immediate access to all course materials and begin your journey today.
Enroll in Masterclass - $150Enrollment takes under 2 minutes and you get immediate next-step instructions.
Training Outcomes
We track outcomes across cohorts. Here's what the numbers say about mdma-assisted therapy masterclass.
Exit surveys conducted 30 days post-certification. Response rate: 89%. Dropout analysis shows highest attrition occurs during Phase 1 screening module (months 1-3). Post-certification support includes 12 supervised integration calls over 6 months.
Evidence base for MDMA in therapeutic contexts
The following peer-reviewed research supports the therapeutic application of MDMA. These studies inform our curriculum and underscore the importance of evidence-based practice in psychedelic-assisted therapy.
Mitchell, J.M. et al. • 2023 • Nature Medicine
FindingPivotal phase 3 trial (MAPP2): MDMA-assisted therapy significantly reduced PTSD symptoms, with 67% no longer meeting PTSD criteria at endpoint.
View on PubMed(opens in a new tab)Fares-Otero, N.E. et al. • 2026 • European Neuropsychopharmacology
FindingMeta-analysis pooling the MDMA-assisted therapy trials for PTSD: effect sizes, responder rates, and the safety picture across phase 2-3 studies.
View on PubMed(opens in a new tab)Werle, I. et al. • 2024 • Neuroscience & Biobehavioral Reviews
FindingReview of how psychedelics including MDMA affect aversive memory reconsolidation and fear extinction — the mechanism behind MDMA-assisted trauma therapy.
View on PubMed(opens in a new tab)Ramaekers, J.G. et al. • 2026 • Molecular Psychiatry
FindingControlled profiling of clinical MDMA doses: subjective and cognitive effects that define the therapeutic window.
View on PubMed(opens in a new tab)4 peer-reviewed studies curated from PubMed and clinical trial registries.
Browse the full research databaseThe goal is clarity - scientifically, clinically, and ethically.
Start with what MDMA-Assisted Therapy is and is not, how it differs from recreational use, and the current evidence landscape.
Move deeper into the biological and clinical mechanisms that make MDMA therapeutically distinct.
Understand evolving regulatory structures, scope boundaries, informed consent standards, and referral thresholds.
Preparation is treated as treatment itself, with focus on readiness assessment, alliance, setting, and role clarity.
Bridge theory and practice with dosing frameworks, therapeutic pacing, trauma-processing support, and dysregulation response.
Integration is presented as the mechanism of durable transformation, not an afterthought.
Important Clarification
This masterclass is educational in nature and does not certify participants to administer MDMA. Participants remain responsible for complying with all applicable laws, licensing regulations, and scope-of-practice requirements.
A structured pathway designed to take you from foundational science to advanced facilitation mastery.
A grounded understanding of MDMA-Assisted Therapy before application.
For further reading on the science and clinical context behind this training:
Why Mindscape
Not the easiest path. The one that actually prepares you.
Every graduate evaluated on ethical competency, not just attendance.
Built on clinical best practices, not weekend workshop shortcuts.
Real container, real accountability, real professional standards.
What graduates say
Here's what people say after completing our programs.
“The depth of this training surprised me. It's not just theory — you're pushed to actually embody the material. I came out a fundamentally different facilitator.”
Dr. Sarah M.
Clinical Psychologist
5-MeO-DMT Facilitation
“I'd done three other psychedelic trainings before this. None of them came close to the rigor and ethical grounding here. This is what the field needs.”
James T.
Integration Coach
5-MeO-DMT Facilitation
“The interview process alone told me this program takes standards seriously. The curriculum delivered exactly what was promised — no fluff, no spiritual bypassing.”
Maria L.
LMFT, Private Practice
Ketamine-Assisted Therapy
“What sets Mindscape apart is the accountability. You're not just watching videos — you're being evaluated on actual competency. That matters when you're working with people in altered states.”
David R.
Harm Reduction Specialist
5-MeO-DMT Facilitation
“I was skeptical about another certification program. But the curriculum structure, the live components, and the ethical framework are genuinely best-in-class.”
Dr. Rachel K.
Psychiatrist
Ketamine-Assisted Therapy
“The masterclass format was perfect for my schedule. Deep content, well-organized, and immediately applicable to my practice. Worth every penny.”
Alex P.
Licensed Therapist
MDMA Masterclass
Have questions? Chat with us!